Heterogeneity and subtypes of CD4+ regulatory T cells: implications for tumor therapy
oleh: Hanqing Lin, Hanqing Lin, Yuanteng Xu, Yuanteng Xu, Chang Lin, Chang Lin
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2024-01-01 |
Deskripsi
In the conventional view, CD4+ regulatory T cell (Treg) represents a subset of lymphocytes that involve the perception and negative regulation of the immune response. CD4+Treg plays an important role in the maintenance of immune homeostasis and immune tolerance. However, recent studies have revealed that CD4+Treg do not suppress the immune response in some diseases, but promote inflammatory injury or inhibit tissue remodeling, suggesting the functional heterogeneity of CD4+Treg. Their involvement in tumor pathogenesis is more complex than previously understood. This article reviews the relevant research on the heterogeneity of CD4+Treg, subtype classification, and their relationship with tumor therapy.